When should venous tumor thrombus in RCC be managed urgently?
This week, @vidit_sharma_ joins @DSRoberson93 to discuss embolic risk, patient optimization, and practical decision-making in managing venous tumor thrombus in renal cell carcinoma #URO300@MayoUrology
https://t.co/bDyGNC92r8
A validated prediction tool is now available to assess metastatic recurrence risk post-surgery for non-metastatic renal cell carcinoma with venous tumor thrombus. https://t.co/5cGF8rf9d5 @UroOnc
What do you do when metastatic urothelial cancer has a dramatic response to systemic therapy? This week, @abhinav__khanna and @DSRoberson93 discuss consolidative cystectomy and the evolving role of surgery in advanced disease #URO290
https://t.co/gX4CMpJaCj
Good chat w/ great friends re: consolidative surgery in advanced urothelial carcinoma
An emerging paradigm of surgical consolidation opens an opportunity for cessation systemic therapy w/ definitive pathologic staging
Initial results @EuropeanUrology
with more data to come!
📺 In a new series, @DSRoberson93 and @abhinav__khanna of @MayoUrology and @NitinYerram of @HUMCUrology explore cytoreductive cystectomy in the post–EV-302 era.
👉 Learn how the success of EV-302 has created a subset of patients with durable responses: https://t.co/5P9HHu82EI
Excited to share our second year Urologic Oncology fellow, Dan Roberson, MD, as the featured SUO fellow in the most recent issue of @UrolOncol to honor the amazing accomplishments of SUO fellows. Click the link below to get to know @dsroberson93 better!
https://t.co/KLCQffnsS3
How fast do #rcc tumor thrombi grow? 📈 In our cohort @MayoUrology (n=141), venous tumor thrombi expanded ~1 cm/month (wide range). Faster growth seen with higher Mayo level, sarcomatoid/rhabdoid features & metastasis. These data can guide pre-op imaging & surgical triage.
🚨 New in European Urology:
Consolidative surgery after #EnfortumabVedotin +/– ICI in advanced urothelial carcinoma:
✅ 82% downstaging
✅ 43% ypT0N0
✅ 79% stopped systemic therapy
✅ 89% DFS in curative group
📄 https://t.co/Yd52YZKRNk
#BladderCancer#Immunotherapy#Urology
In analysis of over 2,000 open RC patients, Mayo Clinic researchers found that prophylactic iNPWT was associated with lower odds of SSI. Further investigation is warranted though this low cost/risk intervention may reduce morbidity for select patients
https://t.co/IIsWJzfsZC
Bladder tumor hard to reach intraluminally or pt not TURBT candidate? In 59 percutaneous biopsies, 95% diagnostic yield, 93% concordance with TURBT/surgical pathology, 0% bladder perf/leak. Another tool for #bladdercancer providers.
https://t.co/sFLKWkJUsi
Congrats to @MayoUrology researchers on their ⭐first-ever exploration of a new frontier in advanced urothelial carcinoma!
Historically consolidative surgery was rare in metastatic UC but with unprecedented responses to EV/Pembro the paradigm is shifting.
https://t.co/xGwwechpq5
Excited to welcome AUA Visiting Scholar Dr. Harshit Garg to @MayoClinic! He shared an insightful talk on the transformative role of #AI in medicine — from diagnostics to decision-making. The future is here, and it's intelligent. @AmerUrological#ArtificialIntelligence@Garg_H
On Sunday at #AUA25, don't miss @DSRoberson93 presenting "Venous Tumor Thrombus in Upper Tract Urothelial Carcinoma: A Clinicopathologic, Operative, and Outcomes Analysis of a Contemporary Cohort"
April 27th, 2025: 9:00am
@AmerUrological
Catch the Monday 7am poster session! @DSRoberson93 will present "Renal Cell Carcinoma with Venous Tumor Thrombus: Histologic Characterization of the Non-Neoplastic Parenchymal Microstructure and the Risk of Chronic Kidney Disease Progression". April 28, Casanova 501 #AUA25#RCC
Don't miss @dsroberson93 presenting "A Prospective Pilot Study of Ex-Vivo High Frequency Ultrasound to Improve Clinical Tumor Staging of Urothelial Carcinoma of the Bladder"
Monday, April 28, 3:30 pm poster session
#AUA24@AmerUrological
Don't miss @DSRoberson93 presenting "The Association Between Artificial Intelligence Generated Renal Tumor Three-Dimensional Contact Surface Area and Partial Nephrectomy Outcomes"
Tuesday, April 29, 2025, 8:28 am podium
Galileo 1001
#AUA25
Be sure to catch @DSRoberson93 presenting "Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis"
April 29, 10:18 am podium
Marco Polo 805
#AUA25